Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Neoplasms

Explore clinical trials studying Central Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

534 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Neoplasms trial results

Completed

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

NCT00006025

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

NCT00004041

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

NCT00003176

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

O(6)-Benzylguanine in Treating Patients With Malignant Glioma

NCT00002971

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

NCT00027625

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

NCT00003616

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma

NCT00010049

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

NCT00004868

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Fenretinide in Treating Patients With Recurrent Malignant Glioma

NCT00006080

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions